Emerging roles for pharmacists in clinical implementation of pharmacogenomics.

Abstract:

:Pharmacists are uniquely qualified to play essential roles in the clinical implementation of pharmacogenomics. However, specific responsibilities and resources needed for these roles have not been defined. We describe roles for pharmacists that emerged in the clinical implementation of genotype-guided clopidogrel therapy in the University of Florida Health Personalized Medicine Program, summarize preliminary program results, and discuss education, training, and resources needed to support such programs. Planning for University of Florida Health Personalized Medicine Program began in summer 2011 under leadership of a pharmacist, with clinical launch in June 2012 of a clopidogrel-CYP2C19 pilot project aimed at tailoring antiplatelet therapies for patients undergoing percutaneous coronary intervention and stent placement. More than 1000 patients were genotyped in the pilot project in year 1. Essential pharmacist roles and responsibilities that developed and/or emerged required expertise in pharmacy informatics (development of clinical decision support in the electronic medical record), medication safety, medication-use policies and processes, development of group and individual educational strategies, literature analysis, drug information, database management, patient care in targeted areas, logistical issues in genetic testing and follow-up, research and ethical issues, and clinical precepting. In the first 2 years of the program (1 year planning and 1 year postimplementation), a total of 14 different pharmacists were directly and indirectly involved, with effort levels ranging from a few hours per month, to 25-30% effort for the director and associate director, to nearly full-time for residents. Clinical pharmacists are well positioned to implement clinical pharmacogenomics programs, with expertise in pharmacokinetics, pharmacogenomics, informatics, and patient care. Education, training, and practice-based resources are needed to support these roles and to facilitate the development of financially sustainable pharmacist-led clinical pharmacogenomics practice models.

journal_name

Pharmacotherapy

journal_title

Pharmacotherapy

authors

Owusu-Obeng A,Weitzel KW,Hatton RC,Staley BJ,Ashton J,Cooper-Dehoff RM,Johnson JA

doi

10.1002/phar.1481

subject

Has Abstract

pub_date

2014-10-01 00:00:00

pages

1102-12

issue

10

eissn

0277-0008

issn

1875-9114

journal_volume

34

pub_type

杂志文章,评审
  • Klebsiella pneumoniae carbapenemases in Enterobacteriaceae: history, evolution, and microbiology concerns.

    abstract::Since the discovery of penicillin 80 years ago, gram-negative bacteria have become proficient at evading the lethal activity of β-lactam antibiotics, principally through the production of β-lactamases. The rapid emergence of penicillinases in both gram-positive and gram-negative bacteria led to the development of ceph...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/j.1875-9114.2012.01035.x

    authors: Rapp RP,Urban C

    更新日期:2012-05-01 00:00:00

  • Preparing clinical pharmacy scientists for careers in clinical/translational research: can we meet the challenge?: ACCP Research Affairs Committee Commentary.

    abstract::Developing clinical pharmacists' research skills and their ability to compete for extramural funding is an important component of the American College of Clinical Pharmacy's (ACCP) vision for pharmacists to play a prominent role in generating the new knowledge used to guide patient pharmacotherapy. Given the recent em...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1348

    authors: Parker RB,Ellingrod V,DiPiro JT,Bauman JL,Blouin RA,Welage LS

    更新日期:2013-12-01 00:00:00

  • Management of herpesvirus infections in the healthy host.

    abstract::Human herpesvirus infections continue to be a concern in immunocompetent as well as immunocompromised hosts. They are often life threatening in the immunocompromised patient. In the healthy immunocompetent person the infections tend to be self-limited, although they can directly or indirectly cause periods of severe d...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:

    authors: Dudley MN

    更新日期:1995-09-01 00:00:00

  • Current guidelines for treatment of heart failure: 2006 update.

    abstract::Several pivotal clinical trials have generated new knowledge regarding drug therapy for heart failure. Thus, the Heart Failure Society of America (HFSA) and the American College of Cardiology-American Heart Association (ACC-AHA) guidelines were updated in 2006 and 2005, respectively. We review the evidence from these ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.27.4part2.12S

    authors: Uddin N,Patterson JH

    更新日期:2007-04-01 00:00:00

  • Role of the pharmacist.

    abstract::The prevalence of cardiovascular risk factors continues to rise, with considerable emphasis on the upward trends in obesity and diabetes mellitus, which have increased by 46% and 60%, respectively, in the past 10 years. The alarming increase in the prevalence of diabetes and obesity has resulted in the development of ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.26.12part2.227S

    authors: Bottorff M

    更新日期:2006-12-01 00:00:00

  • Severe withdrawal syndrome possibly associated with cessation of a midazolam and fentanyl infusion.

    abstract::A 40-month-old child was sedated with a fentanyl and midazolam infusion for 7 days. After the drugs were discontinued he became unresponsive and globally aphasic, and had marked thrombocytosis. He was hospitalized for 4 weeks, during which time his motor and cognitive status slowly improved, and had almost returned to...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/j.1875-9114.1995.tb02877.x

    authors: Ducharme MP,Munzenberger P

    更新日期:1995-09-01 00:00:00

  • Administration of glycoprotein IIb-IIIa inhibitors in patients with ST-segment elevation myocardial infarction.

    abstract::Patients with ST-segment elevation acute myocardial infarction require immediate reperfusion therapy. Reperfusion therapy can be provided by either pharmacologic or mechanical means. Pharmacologic reperfusion therapy consists of administering fibrinolytics, whereas mechanical reperfusion consists of performing percuta...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.22.11.864.33632

    authors: Dobesh PP,Kasiar JB

    更新日期:2002-07-01 00:00:00

  • Reteplase for dysfunctional hemodialysis catheter clearance.

    abstract:STUDY OBJECTIVE:To evaluate the efficacy of reteplase administration in clearing hemodialysis catheters. DESIGN:Open-label, uncontrolled, observational trial. SETTING:University medical center. PATIENTS:Thirty-four patients with end-stage renal disease undergoing long-term hemodialysis. INTERVENTION:Patients had du...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章

    doi:10.1592/phco.23.2.137.32086

    authors: Hilleman DE,Dunlay RW,Packard KA

    更新日期:2003-02-01 00:00:00

  • Reversible akinetic mutism possibly induced by baclofen.

    abstract::A 76-year-old man developed akinetic mutism after 3 days of receiving low-dosage baclofen. Electroencephalography showed a diffusely slow background with intermittent generalized sharp wave discharges. The condition resolved after discontinuing baclofen. To our knowledge, this is the first reported case of baclofen-in...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.19.6.468.31053

    authors: Rubin DI,So EL

    更新日期:1999-04-01 00:00:00

  • The effect of low-dose phenytoin on high-density lipoprotein cholesterol.

    abstract::We examined whether low doses of phenytoin, which should be associated with few dose-related side effects, may increase the levels of high-density lipoprotein (HDL) cholesterol. Of 35 healthy adult men who consented to participate, 31 completed the study. They took no medications and consumed no alcohol during the stu...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: McKenney JM,Petrizzi KS,Briggs GC,Wright JT Jr

    更新日期:1992-01-01 00:00:00

  • Ceftaroline-induced eosinophilic pneumonia.

    abstract::We present a case of eosinophilic pneumonia due to ceftaroline used for the treatment of methicillin-resistant Staphylococcus aureus bacteremia associated with a postoperative spinal infection. Our patient developed shortness of breath and hypoxemia on the fifth week of ceftaroline therapy. Chest imaging disclosed dif...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1286

    authors: Desai KR,Burdette SD,Polenakovik HM,Hagaman J,Pleiman CM

    更新日期:2013-07-01 00:00:00

  • Anaphylactoid reaction to enoxaparin in a patient with deep venous thrombosis.

    abstract::A 40-year-old Caucasian man diagnosed with right deep venous thrombosis secondary to trauma was treated with subcutaneous enoxaparin. Within minutes of administering the first dose (1 mg/kg), he experienced an apparent anaphylactoid reaction; symptoms were abdominal pruritus, severe cough, shortness of breath, anxiety...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.22.16.1511.33688

    authors: MacLaughlin EJ,Fitzpatrick KT,Sbar E,Jewell C

    更新日期:2002-11-01 00:00:00

  • Glucagon for Relief of Acute Esophageal Foreign Bodies and Food Impactions: A Systematic Review and Meta-Analysis.

    abstract::Glucagon is frequently used for the relief of esophageal impactions. This systematic review and meta-analysis were performed to evaluate the efficacy and safety of glucagon for acute esophageal foreign body and food impactions. PubMed, CINAHL, Latin American and Caribbean Health Sciences Literature (LILACS), Scopus, C...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,meta分析

    doi:10.1002/phar.2236

    authors: Peksa GD,DeMott JM,Slocum GW,Burkins J,Gottlieb M

    更新日期:2019-04-01 00:00:00

  • Olanzapine-associated neuroleptic malignant syndrome in a patient receiving concomitant rivastigmine therapy.

    abstract::Neuroleptic malignant syndrome (NMS) is an idiosyncratic and uncommon but serious adverse effect that has been reported with both typical and atypical antipsychotic agents. We describe a 58-year-old man with Down syndrome and dementia who was receiving low-dose olanzapine and rivastigmine therapy; he developed NMS 4 m...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.28.3.403

    authors: Stevens DL,Lee MR,Padua Y

    更新日期:2008-03-01 00:00:00

  • Implications of cytochrome P450 2C9 polymorphism on warfarin metabolism and dosing.

    abstract::Warfarin is an anticoagulant available as a racemic mixture. The R- and S-isomers differ with respect to relative plasma concentrations, clearance, potency, sites of metabolism, and cytochrome P450 (CYP) isoenzymes responsible for metabolism. S-Warfarin, the more potent isomer, is metabolized primarily by CYP2C9. Gene...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.21.2.235.34106

    authors: Redman AR

    更新日期:2001-02-01 00:00:00

  • Safe administration of iron sucrose in a patient with a previous hypersensitivity reaction to ferric gluconate.

    abstract::A 67-year-old woman with iron deficiency anemia required parenteral iron therapy and was treated with intravenous ferric gluconate. She tolerated the first dose, but after the second dose, she developed a tingling feeling all over her body, along with swelling in her hands and feet, and a rash with hives over most of ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.27.4.613

    authors: Sane R,Baribeault D,Rosenberg CL

    更新日期:2007-04-01 00:00:00

  • Principles of drug literature evaluation for observational study designs.

    abstract::Clinical pharmacists must often interpret and use data derived from observational studies when making clinical decisions and recommendations, answering drug information questions, and educating patients about drug therapy. This is the third article in a three-part series intended to enhance clinical pharmacists' under...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.31.2.115

    authors: Shields KM,DiPietro NA,Kier KL

    更新日期:2011-02-01 00:00:00

  • Association of vancomycin serum concentrations with outcomes in patients with gram-positive bacteremia.

    abstract::We attempted to determine if an association exists between vancomycin serum concentrations resulting from traditional dosing regimens, and efficacy and toxicity outcomes. We reviewed the medical charts of 273 consecutive patients prescribed 273 courses of vancomycin therapy for documented, gram-positive bacteremia. Of...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Zimmermann AE,Katona BG,Plaisance KI

    更新日期:1995-01-01 00:00:00

  • Analysis of the analgesic efficacy of acetaminophen 1000 mg, codeine phosphate 60 mg, and the combination of acetaminophen 1000 mg and codeine phosphate 60 mg in the relief of postoperative pain.

    abstract::Patients who experienced pain after surgery were administered a single dose of 1 of 3 treatments: acetaminophen 1000 mg, codeine phosphate 60 mg, or a combination of these. Patients rated their pain intensity on ordinal and visual analog scales just prior to medication and at intervals thereafter for up to 5 hours. Th...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章

    doi:10.1002/j.1875-9114.1986.tb03462.x

    authors: Gertzbein SD,Tile M,McMurty RY,Kellam JF,Hunter GA,Keith RG,Harsanyi Z,Luffman J

    更新日期:1986-05-01 00:00:00

  • Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment options.

    abstract::Pseudomonas aeruginosa is one of the leading gram-negative organisms associated with nosocomial infections. The increasing frequency of multi-drug-resistant Pseudomonas aeruginosa (MDRPA) strains is concerning as efficacious antimicrobial options are severely limited. By searching MEDLINE from January 1966-February 20...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.2005.25.10.1353

    authors: Obritsch MD,Fish DN,MacLaren R,Jung R

    更新日期:2005-10-01 00:00:00

  • Resolution of a phytobezoar with Aldoph's Meat Tenderizer.

    abstract::A 58-year-old man went to his physician with complaints of midepigastric pain, flatulence, belching, and shortness of breath. During a physical examination, the patient was in no acute distress. The patient underwent an ultrasound examination, which revealed cholelithiasis, a laparoscopic cholecystectomy, which reveal...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.27.2.299

    authors: Baker EL,Baker WL,Cloney DJ

    更新日期:2007-02-01 00:00:00

  • Serum sickness associated with 6-mercaptopurine in a patient with Crohn's disease.

    abstract::A 43-year-old man with a 19-year history of Crohn's disease experienced serum sickness with acute lobular panniculitis and vasculitis within 2 weeks of initiating 6-mercaptopurine therapy. He had no history of extraintestinal manifestations of Crohn's disease or drug allergy. Symptoms included disabling joint pain, pr...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Andersen JM,Tiede JJ

    更新日期:1997-01-01 00:00:00

  • Stress-dose corticosteroid therapy for sepsis and acute lung injury or acute respiratory distress syndrome in critically ill adults.

    abstract::Sepsis and acute lung injury (ALI) or acute respiratory distress syndrome (ARDS) are associated with high mortality rates despite recent therapeutic advances. Both disease states involve uncontrolled host defense responses that lead to inflammation, endothelial damage, enhanced coagulation, diminished fibrinolysis and...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.22.13.1140.33519

    authors: MacLaren R,Jung R

    更新日期:2002-09-01 00:00:00

  • Tissue plasminogen activator: an evaluation of clinical efficacy in acute myocardial infarction.

    abstract::Recombinant tissue plasminogen activator (t-PA) is a synthetic fibrinolytic protein which activates plasminogen or converts plasminogen to plasmin specifically in the presence of fibrin. With its "clot-selectivity", t-PA is capable of lysing clots without having a significant effect on circulating plasminogen. In cont...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/j.1875-9114.1987.tb04035.x

    authors: Rogers SD,Riemersma LB,Clements SD

    更新日期:1987-01-01 00:00:00

  • Olanzapine-associated severe hyperglycemia, ketonuria, and acidosis: case report and review of literature.

    abstract::Olanzapine has been associated with insulin resistance and new-onset diabetes mellitus. A 27-year-old African-American man developed new-onset severe hyperglycemia-glucose 1240 mg/dl, with ketonuria and acidosis, but no weight gain-2 years after starting olanzapine. Although his diabetes was stabilized with insulin, h...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.21.17.1448.34421

    authors: Seaburg HL,McLendon BM,Doraiswamy PM

    更新日期:2001-11-01 00:00:00

  • Effects of antiepileptic drug substitutions on epileptic events requiring acute care.

    abstract:STUDY OBJECTIVES:To determine the odds of antiepileptic drug substitution among patients who had an epileptic event requiring acute care-ambulance service, emergency department visit, or hospitalization-relative to patients who did not have an event, and to compare these results with those from a recent study involving...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.29.7.769

    authors: Rascati KL,Richards KM,Johnsrud MT,Mann TA

    更新日期:2009-07-01 00:00:00

  • Efficacy of triclosan as an antimicrobial hand soap and its potential impact on antimicrobial resistance: a focused review.

    abstract::Triclosan is a synthetic biocide found in many household products, including antimicrobial hand soap. Levels of triclosan have been found throughout the environment and in human urine, blood, and even breast milk. Increasing levels of exposure to triclosan have led to concerns over the development of resistance to tri...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.1553

    authors: Giuliano CA,Rybak MJ

    更新日期:2015-03-01 00:00:00

  • Efficacy and safety of low-dose valganciclovir for prevention of cytomegalovirus disease in renal transplant recipients: a single-center, retrospective analysis.

    abstract:STUDY OBJECTIVE:To evaluate the safety and efficacy of valganciclovir 450 mg/day for 6 months for cytomegalovirus (CMV) prophylaxis in renal transplant recipients. DESIGN:Single-center, retrospective analysis. SETTING:Urban, academic medical center. PATIENTS:Fifty-eight patients who received de novo renal transplant...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.24.14.1323.43152

    authors: Gabardi S,Magee CC,Baroletti SA,Powelson JA,Cina JL,Chandraker AK

    更新日期:2004-10-01 00:00:00

  • Two-year changes in bone mineral density and T scores in patients treated at a pharmacist-run teriparatide clinic.

    abstract:STUDY OBJECTIVES:To determine changes in bone mineral density (BMD) and T scores of patients after 2 years of teriparatide therapy, and to determine the number of fractures that occurred during therapy. DESIGN:Prospective, observational study. SETTING:Pharmacist-run teriparatide clinic in a private-practice endocrino...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章

    doi:10.1592/phco.27.6.779

    authors: Stroup JS,Rivers SM,Abu-Baker AM,Kane MP

    更新日期:2007-06-01 00:00:00

  • Follow-up of adverse drug reactions from peginterferon alfa-2b-ribavirin therapy.

    abstract:STUDY OBJECTIVE:To investigate the adverse drug reactions (ADRs) from peginterferon alfa-2b plus ribavirin in patients infected with the hepatitis C virus (HCV). DESIGN:Prospective, observational, pharmacovigilance study. SETTING:Gastroenterology department of a French university hospital. PATIENTS:A cohort of conse...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.24.16.1546.50947

    authors: Bagheri H,Fouladi A,Barange K,Lapeyre-Mestre M,Payen JL,Montastruc JL,Vinel JP

    更新日期:2004-11-01 00:00:00